| 1 |
29541403 | Combination of AKT inhibitor ARQ 092 and sorafenib potentiates inhibition of tumor progression in cirrhotic rat model of hepatocellular carcinoma. | 2018 Feb 16 |
2 |
| 2 |
28566435 | Efficacy of AKT Inhibitor ARQ 092 Compared with Sorafenib in a Cirrhotic Rat Model with Hepatocellular Carcinoma. | 2017 Oct |
1 |
| 3 |
24976727 | Distinct antifibrogenic effects of erlotinib, sunitinib and sorafenib on rat pancreatic stellate cells. | 2014 Jun 28 |
1 |
| 4 |
23043394 | Sorafenib treatment improves hepatopulmonary syndrome in rats with biliary cirrhosis. | 2013 Apr |
1 |
| 5 |
22428038 | Activation of PI3K/AKT and MAPK pathway through a PDGFRβ-dependent feedback loop is involved in rapamycin resistance in hepatocellular carcinoma. | 2012 |
1 |
| 6 |
22025881 | Sorafenib inhibits growth and metastasis of hepatocellular carcinoma by blocking STAT3. | 2011 Sep 14 |
6 |
| 7 |
20447716 | New insights into the antifibrotic effects of sorafenib on hepatic stellate cells and liver fibrosis. | 2010 Jul |
1 |